Monopar Therapeutics Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$5.46 | $223.86 M | -2.51 | 58 | $0 |
ACXP
Acurx Pharmaceuticals, Inc. |
$0.86 | $38.02 M | -2.03 | 4 | $0 |
ADAG
Adagene Inc. |
$1.93 | $131.46 M | -6.77 | 174 | $18.11 M |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.45 | $56.28 M | -5.86 | 2 | $0 |
ANTX
AN2 Therapeutics, Inc. |
$1.26 | $60.55 M | -0.81 | 41 | $0 |
AVTE
Aerovate Therapeutics, Inc. |
$2.60 | $597.48 M | -6.84 | 51 | $0 |
CADL
Candel Therapeutics, Inc. |
$6.89 | $212.76 M | -5.54 | 42 | $0 |
DMAC
DiaMedica Therapeutics Inc. |
$6.32 | $97.19 M | -4.74 | 18 | $0 |
ENOB
Enochian Biosciences, Inc. |
$0.71 | $45.38 M | -0.34 | 22 | $0 |
KTTA
Pasithea Therapeutics Corp. |
$2.45 | $5.84 M | -0.41 | 8 | $0 |
MLYS
Mineralys Therapeutics, Inc. |
$10.01 | $652.38 M | -6.03 | 28 | $0 |
MOLN
Molecular Partners AG |
$5.33 | $135.05 M | -2.03 | 167 | $7.04 M |
PEPG
PepGen Inc. |
$1.93 | $537.15 M | -5.11 | 76 | $0 |
PHVS
Pharvaris N.V. |
$18.84 | $843.31 M | -5.8 | 83 | $0 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.38 | $85.40 M | -1.26 | 63 | $0 |
RZLT
Rezolute, Inc. |
$4.82 | $229.57 M | -5.02 | 59 | $0 |
SCPH
scPharmaceuticals Inc. |
$3.29 | $135.20 M | -2.53 | 135 | $13.59 M |
SCPS
Scopus BioPharma Inc. |
$0.00 | $4,208 | 0 | 13 | $0 |